These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 29738424
1. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Diem SJ, Guthrie KA, Mitchell CM, Reed SD, Larson JC, Ensrud KE, LaCroix AZ. Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424 [Abstract] [Full Text] [Related]
3. Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, LaCroix AZ, Caan B, Guthrie KA. JAMA Intern Med; 2018 May 01; 178(5):681-690. PubMed ID: 29554173 [Abstract] [Full Text] [Related]
4. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women. Mitchell CM, Guthrie KA, Larson J, Diem S, LaCroix AZ, Caan B, Shifren JL, Woods NF, Heiman JR, Lindau ST, Reed SD. Menopause; 2019 Aug 01; 26(8):816-822. PubMed ID: 30994576 [Abstract] [Full Text] [Related]
6. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. Archer DF, Kimble TD, Lin FDY, Battucci S, Sniukiene V, Liu JH. J Womens Health (Larchmt); 2018 Mar 01; 27(3):231-237. PubMed ID: 29193980 [Abstract] [Full Text] [Related]
7. TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial. Kingsberg SA, Derogatis L, Simon JA, Constantine GD, Graham S, Bernick B, Gasper G, Mirkin S. J Sex Med; 2016 Dec 01; 13(12):1930-1937. PubMed ID: 27692842 [Abstract] [Full Text] [Related]
8. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study. De Seta F, Caruso S, Di Lorenzo G, Romano F, Mirandola M, Nappi RE. Maturitas; 2021 May 01; 147():34-40. PubMed ID: 33832645 [Abstract] [Full Text] [Related]
9. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Gilbert L, Martel C, Balser J. J Sex Med; 2014 Jul 01; 11(7):1766-85. PubMed ID: 24774442 [Abstract] [Full Text] [Related]
10. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy. Bachmann G, Bobula J, Mirkin S. Climacteric; 2010 Apr 01; 13(2):132-40. PubMed ID: 19863455 [Abstract] [Full Text] [Related]
11. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Caruso S, Cianci S, Amore FF, Ventura B, Bambili E, Spadola S, Cianci A. Menopause; 2016 Jan 01; 23(1):47-54. PubMed ID: 26079974 [Abstract] [Full Text] [Related]
13. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Caan B, LaCroix AZ, Joffe H, Guthrie KA, Larson JC, Carpenter JS, Cohen LS, Freeman EW, Manson JE, Newton K, Reed S, Rexrode K, Shifren J, Sternfeld B, Ensrud K. Menopause; 2015 Jun 01; 22(6):607-15. PubMed ID: 25405571 [Abstract] [Full Text] [Related]
14. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation. Mitchell CM, Ma N, Mitchell AJ, Wu MC, Valint DJ, Proll S, Reed SD, Guthrie KA, Lacroix AZ, Larson JC, Pepin R, Raftery D, Fredricks DN, Srinivasan S. Am J Obstet Gynecol; 2021 Aug 01; 225(2):159.e1-159.e15. PubMed ID: 33675793 [Abstract] [Full Text] [Related]
15. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. Vale F, Rezende C, Raciclan A, Bretas T, Geber S. Eur J Obstet Gynecol Reprod Biol; 2019 Mar 01; 234():92-95. PubMed ID: 30677618 [Abstract] [Full Text] [Related]
16. Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial. Hunter MM, Guthrie KA, Larson JC, Reed SD, Mitchell CM, Diem SJ, LaCroix AZ, Huang AJ. J Sex Med; 2020 Jan 01; 17(1):117-125. PubMed ID: 31812686 [Abstract] [Full Text] [Related]
17. Impact of Topical Interventions on the Vaginal Microbiota and Metabolome in Postmenopausal Women: A Secondary Analysis of a Randomized Clinical Trial. Srinivasan S, Hua X, Wu MC, Proll S, Valint DJ, Reed SD, Guthrie KA, LaCroix AZ, Larson JC, Pepin R, Bhasin S, Raftery D, Fredricks DN, Mitchell CM. JAMA Netw Open; 2022 Mar 01; 5(3):e225032. PubMed ID: 35353163 [Abstract] [Full Text] [Related]
18. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Parsons A, Merritt D, Rosen A, Heath H, Siddhanti S, Plouffe L, Study Groups on the Effects of Raloxifene HCI With Low-Dose Premarin Vaginal Cream. Obstet Gynecol; 2003 Feb 01; 101(2):346-52. PubMed ID: 12576260 [Abstract] [Full Text] [Related]